Re-evaluating the health impact and cost-effectiveness of tuberculosis preventive treatment for modern HIV cohorts on antiretroviral therapy: a modelling analysis using data from Tanzania

BACKGROUND: Isoniazid preventive therapy (IPT) can prevent tuberculosis among people receiving antiretroviral therapy (ART). HIV programmes are now initiating patients on ART with higher average CD4 cell counts and lower tuberculosis risks under test-and-treat guidelines. We aimed to investigate how...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jinyi, Lyatuu, Goodluck, Sudfeld, Christopher R, Kiravu, Anna, Sando, David, Machumi, Lameck, Minde, John, Chisonjela, Fikiri, Cohen, Ted, Menzies, Nicolas A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553191/
https://www.ncbi.nlm.nih.gov/pubmed/36240830
http://dx.doi.org/10.1016/S2214-109X(22)00372-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553191/
https://www.ncbi.nlm.nih.gov/pubmed/36240830
http://dx.doi.org/10.1016/S2214-109X(22)00372-2

Ejemplares similares